Short Biography of Dr Deborah Szafir

Deborah Szafir is Vice President of Pierre Fabre Worldwide Corporate International Quality, Regulatory, Vigilances and Medical Information : contributes throughout the life cycle of the products in developing and securing the business while guaranteeing ethics and quality of processes and products and insuring patient’s safety.


Prior to join Pierre Fabre, Deborah was head of EU Regulatory liaison at Hoffman-La Roche. : represents the global regulatory function on general policy matters and critical product issues with EU regulatory agencies, advises on EU regulatory strategy, develops with heads of EU regulatory affiliates strategies to enhance relationships with local health authorities.

Before, Deborah was head of Safety Risk Management strategy at Hoffmann-LaRoche : develops relationships with the major Health Authorities and represents Roche on advancing the science of Safety Risk Management, contributes to the evolution of policies and guidelines, coordinates other similar strategic initiatives in various Pharma organizations and key stakeholder organizations representing the physicians and the patients. Before that, Deborah was head of Communication and congresses at Hoffman-La Roche and prior to that, was Global Drug Safety Affiliate Director and European QP at Roche.


Deborah is graduate of the faculty of Medicine of Paris Creteil Val de Marne with 2 years’experience of surgery in French, UK and Israel’s hospital as first operative assistant and training placements, 2 years of experience working for Health Authorities within one of the 31st French regional Centre (Pharmacology’s department of Prof.Tillement in Creteil) and 16 years in the pharmaceutical industry in senior medical positions including 10 years of European/International experience as European Drug Safety Coordinator (Qualified Person for Pharmacovigilance), Globad Head of Drug Safety Affiliates and EU Regulatory liaison.

Dr Deborah Szafir

Vice President of Pierre Fabre Worldwide Corporate International Quality, Regulatory, Vigilances and Medical Information. FR.